Citius Pharmaceuticals Inc

General ticker "CTXR" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $526.0M

Citius Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -30.7%.

Estimated limits based on current volatility of 6.4%: low 2.44$, high 2.78$

Factors to consider:

  • Earnings expected soon, date: nan
  • Current price 64.3% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-09-30 to 2025-09-29

  • 2023-09-30 to 2024-09-29 estimated range: [10.34$, 25.42$]
  • 2024-09-29 to 2025-09-29 estimated range: [8.16$, 20.23$]

Financial Metrics affecting the CTXR estimates:

  • Negative: Non-GAAP EPS, $ of -0.24 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -19.19 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of -2.94 <= -0.39

Similar symbols

Short-term CTXR quotes

Long-term CTXR plot with estimates

Financial data

YTD 2021-09-30 2022-09-30 2023-09-30
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $23.53MM $33.32MM $36.73MM
Operating Income $-23.53MM $-33.32MM $-36.73MM
Non-Operating Income $0.48MM $0.25MM $4.77MM
Interest Expense $0.01MM $0.00MM $0.00MM
R&D Expense $12.24MM $17.66MM $14.82MM
Income(Loss) $-23.05MM $-33.06MM $-31.97MM
Taxes $0.00MM $0.58MM $0.58MM
Profit(Loss) $-23.05MM $-33.64MM $-32.54MM
Stockholders Equity $132.18MM $102.83MM $90.83MM
Assets $142.43MM $114.00MM $103.61MM
Operating Cash Flow $-24.25MM $-28.36MM $-29.06MM
Capital expenditure $40.01MM $0.00MM $0.00MM
Investing Cash Flow $-40.01MM $0.00MM $0.00MM
Financing Cash Flow $120.47MM $0.00MM $13.83MM
Earnings Per Share* $-0.21 $-0.23 $-0.23

* EPS are Split Adjusted, recent splits may be reflected with a delay.